Trump administration revisits policy to close Medicare drug price negotiation loophole
Drugmakers say new Medicare drug price negotiation proposal would undermine incentive to develop better versions of drugs.
News Search
Search results for Statnews
Search Results
24 results found
‘I’m pretty much all in’: An interview with a woman starting medical residency at almost 73
She went viral for finishing medical school at 72. On the ‘First Opinion Podcast,’ she talks Caribbean medical school, NPs vs. MDs, and more.
WHO director-general is profoundly concerned after visit to Ebola outbreak area
WHO director-general says in the DRC, war and malaria kill more people than Ebola, and people there told him what they want most is peace.
I’ve spent 40 years in research. I have never seen a threat to science like the new grantmaking rule
The federal government is now proposing to fundamentally rewire scientific research review for no good reason.
FDA approves Sanofi diabetes drug for children with stage 3 diabetes
Former CDER head Tracy Beth Høeg previously disagreed with staff on approval of teplizumab for children with stage 3 diabetes.
Ebola outbreak response requires engaging with religious traditions and leaders
Trusted religious and traditional leaders need to be engaged immediately as the Ebola outbreak spreads rapidly in the DRC and Uganda.
Study highlights influence of socioeconomic status on children’s brain development
Researchers analyze brain scans from 12,000 children to reveal how socioeconomic factors like poverty and stress shape neural development.
Updated: Tracking RFK Jr.’s promises to remake health in America
STAT keeps a promises tracker for Robert F. Kennedy Jr.'s Make America Healthy Again movement — successes, incompletes, fails. Updated June 2026.
RFK Jr. claims his calendar is publicly available. We’ve been trying to get it for a year
Kennedy cited his 'publicly available calendar' as an example of his commitment to transparency. It's never been released, even after repeated FOIA filings
Abridge inks deals with Nvidia and Lilly
Health care AI company Abridge announced new deals with pharma giant Eli Lilly and chip-maker Nvidia, as it aims to gain an edge in a competitive market.
Drinking during pregnancy rose after 2020, new CDC data suggest
CDC says alcohol use during pregnancy rose from 13.5% in 2021 to 15% in 2024, shows an issue thought to be from the past is an ongoing health concern.
Nonprofit buys experimental cancer drug to maintain patient access
In rare move, advocacy group buys up remaining stockpile of an investigational drug, Luvelta. Will be offered at no cost for compassionate use by patients.
An obesity drug deep-dive, and peptides move mainstream
Can any of the new obesity medications in development stand out from the pack? Which company just broke records with its IPO? And will the Food and Drug
How a diabetes conference sparked a controversy
Annual ADA convention, normally a staid affair, sees protesters expelled, controversy erupt and apologies issued. STATus Report host Alex Hogan dives in.
At hospital finance conference, a call to end the friction that’s keeping costs high
At the Healthcare Financial Management Association conference, there was wide agreement that affordability is a major issue. What to do was far less clear.
How long Covid’s scientific stalemate made it politically erasable
Applying the biomedical paradigm to long Covid, a contested illness, has resulted in a scientific stalemate.
We published in Nature Medicine in 2025 for free. In 2026, it cost us $12,850
A new open-access policy has led journals owned by Springer Nature, Wiley, and Elsevier to charge outrageous fees to NIH-funded authors.
Scientists see promise in NIH proposal to cap number of grants they receive
NIH floats cap on concurrent grants to diversify funding. Experts call the idea well-intentioned but worry it won't be implemented fairly.
Private Medicare plans erect barriers to rehab care in pursuit of profit, federal investigators find
Medicare Advantage insurers block care for seniors only to reverse denials on appeal. A new OIG report exposes a potentially profit-driven tactic.
OB-GYN association, deviating from CDC guidance, issues its own vaccine recommendations
The American College of Obstetricians and Gynecologists calls for four shots to be routinely administered in pregnancy.
Your sepsis algorithm shouldn’t require a time machine
In this edition of STAT's AI Prognosis: Quirky health care data tripping up sepsis algorithms, AI scribes for patients, and some AI biotech news.
‘Synthetic lethality’ could trigger another round of biotech M&A
Preliminary data suggest a promising path forward for “synthetic lethality” in the treatment of cancer, and could spur some biotech deal-making.
Enliven Therapeutics’ leukemia drug shows promise in new study
Early data compare favorably to a blockbuster medicine sold by Novartis and an experimental therapy owned by Merck.
Series & Investigations
STAT's award-winning series and investigations include the Polk-award-winning 'American Science Shattered' and the Pulitzer finalist 'Denied by AI.'